[1]
H. Elsebaie, W. S. M. Yassa, S. Lasheen, and N. IbrahimIbrahim, “Efficacy, Safety and Cost Effectiveness of Metronomic Low Dose Versus Intermittent High Dose Capecitabine in Metastatic Breast Cancer”, Open Access Maced J Med Sci, vol. 9, no. B, pp. 1048–1053, Oct. 2021.